|
It was reported to medtronic minimed that the customer experienced hyperglycemia and also reported open book image and replace battery now alarm.The customer reported a blood glucose value of 250 mg/dl.The customer experienced hyperglycemia had an emergency room visit and was treated with intravenous insulin infusion.The customer also experienced symptoms of headache, feeling sick/unwell and extremity pain/cramps at the time of hospitalization.The event involved product(s) mmt-1884, mmt-332a and mmt-386a.Troubleshooting was declined.It was unknown whether the customer was using the insulin pump within 48 hours of the reported event.There is no mention of the auto mode feature at the time of the event.No further patient complications were reported.No product return is required for mmt-1884.No product return is required for mmt-332a.No product return is required for mmt-386a.
|
|
This mdr related to the puerto rico manufacturing site has been assigned a medwatch number from the medtronic minimed northridge site, per variance 5.Currently it is unknown whether or not the device may have caused or contributed to the event.The device has been returned, but not yet evaluated.Further information will follow once the analysis has been completed.No conclusion can be drawn at this time.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employees caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|